On Some Modeling Issues in Estimating Vaccine Efficacy
I would like to reconsider a recent analysis by Prof. Senn on the statistics of the Pfizer-BioNTech vaccine trial, to express some different opinions and to clarify some theoretical points, especially regarding the clinical applications of Bayesian statistics.
Authors
- Mauro Gasparini (ORCID: https://orcid.org/0000-0001-8011-4005)
Institutions
- Politecnico di Torino (IT)
Publication Details
- Journal
- Pharmaceutical Statistics
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1002/pst.2440
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Politecnico di Torino
- Ministero dell'Università e della Ricerca